Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Market price (% of par)
-
99.8%
-
Total 13F principal
-
$28,696,440
-
Principal change
-
+$1,625,500
-
Total reported market value
-
$40,994,280
-
Number of holders
-
9
-
Value change
-
-$5,776,275
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q3 2025
As of 30 Sep 2025,
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by
9 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$28,696,440
in principal (par value) of the bond.
The largest 9 bondholders included
Pentwater Capital Management LP, DeepCurrents Investment Group LLC, PenderFund Capital Management Ltd., OAKTREE CAPITAL MANAGEMENT LP, Jefferies Financial Group Inc., Russell Investments Group, Ltd., Saranac Partners Ltd, ZAZOVE ASSOCIATES LLC, and Context Capital Management, LLC.
This page lists
9
institutional bondholders reporting positions
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.